We are committed to serving the best interests of our shareholders. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc.
NASDAQ: CBIO$10.520.15 (1.45%)Jun 22, 20184:00 p.m. ET
Delayed at least 15 minutes
Data provided by Nasdaq. Minimum 15 minutes delayed.
Press ReleasesJune 19, 2018Catalyst Biosciences to Present at the JMP Securities 2018 Life Sciences ConferenceJune 18, 2018Catalyst Biosciences Provides Update on CB 2679d/ISU304 Factor IX Clinical Program in Hemophilia BMay 10, 2018Catalyst Biosciences Announces Oral Presentation at the World Federation of Hemophilia 2018 World CongressView all press releases »
Reverse Stock Split
|For the 1 for 15 Reverse Stock Split Tax Form, click here|
Targacept Special Dividend
|For the FAQ and additional information, click here.|
Catalyst Biosciences, Inc.
|Josephine Belluardo, Ph.D.|
LifeSci Public Relations